Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1375 of 2873 entries
View as:

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02239900 Org: User:
Start: 08/26/14 End: 10/25/19 Due: 10/25/20

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02532257 Org: User:
Start: 04/11/16 End: 08/15/23 Due: 08/15/24

Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01627093 Org: User:
Start: 01/06/12 End: 04/30/26 Due: 04/30/27

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04220827 Org: User:
Start: 12/06/19 End: 10/30/28 Due: 10/30/29

Discount Generic Prescription Study

Phase: N/A Priority: Normal
NCT ID: NCT00971022 Org: User:
Start: 08/31/09 End: 05/31/11 Due: 05/31/12

Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01198028 Org: User:
Start: 03/10/11 End: 05/01/19 Due: 05/01/20

Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02007044 Org: User:
Start: 12/06/13 End: 06/30/26 Due: 06/30/27

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT05102656 Org: User:
Start: 06/02/21 End: 02/02/27 Due: 02/02/28

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01590082 Org: User:
Start: 11/30/12 End: 07/31/15 Due: 07/31/16

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00080678 Org: User:
Start: 05/31/03 End: 03/31/08 Due: 03/31/09

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

Phase: N/A Priority: Normal
NCT ID: NCT05676450 Org: User:
Start: 02/23/23 End: 08/31/26 Due: 08/31/27

Financial Toxicity in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04592250 Org: User:
Start: 09/12/20 End: 09/01/28 Due: 09/01/29

Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05357469 Org: User:
Start: 07/14/22 End: 07/31/25 Due: 07/31/26

A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT06973668 Org: User:
Start: 10/01/25 End: 01/31/30 Due: 01/31/31

Late Chronic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01092741 Org: User:
Start: 07/31/01 End: 09/30/13 Due: 09/30/14

Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women

Phase: N/A Priority: Normal
NCT ID: NCT05053113 Org: User:
Start: 07/27/22 End: 08/31/25 Due: 08/31/26

Bone Response in Metastatic Breast Cancer Involving Bones

Phase: N/A Priority: Normal
NCT ID: NCT00420433 Org: User:
Start: 09/30/04 End: 05/31/12 Due: 05/31/13

Liver Cancer Prevention Randomized Control Trial

Phase: N/A Priority: Normal
NCT ID: NCT05196867 Org: User:
Start: 02/11/22 End: 08/30/25 Due: 08/30/26

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT01536392 Org: User:
Start: 03/31/12 End: 10/03/19 Due: 10/03/20

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

Phase: N/A Priority: Normal
NCT ID: NCT01946854 Org: User:
Start: 07/16/13 End: 07/31/25 Due: 07/31/26

Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02250937 Org: User:
Start: 10/27/14 End: 10/31/25 Due: 10/31/26

SCH-900105 in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01189513 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00504660 Org: User:
Start: 09/30/03 End: 08/31/10 Due: 08/31/11

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

Phase: N/A Priority: Normal
NCT ID: NCT00671801 Org: User:
Start: 04/29/08 End: 02/28/14 Due: 02/28/15

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00038168 Org: User:
Start: 06/30/00 End: 01/31/03 Due: 01/31/04